Dexcom Inc. Stock
€70.80
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Dexcom Inc. | -4.440% | 7.439% | -1.932% | -30.025% | -1.868% | 4.176% | -17.906% |
Henry Schein Inc. | -0.060% | -0.161% | 0.649% | 3.575% | -7.074% | -15.335% | 19.969% |
Teleflex Inc. | -0.510% | -0.990% | -5.660% | -47.644% | -40.476% | -57.265% | -68.153% |
Baxter International | 0.620% | -0.753% | -4.301% | -17.707% | -7.654% | -58.068% | -66.467% |
Comments
News

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the

Prediction: These 2 Stocks Will Beat the Market in the Next Decade
Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies. Let's consider two corporations that could help you do

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his current role as chief